🔎 Trials Near Me

Gara Jalqabaatti › Myeloma Baay’ee › Washington › Tacoma

Qorannoo klinikaalii Myeloma Baay’ee Tacoma, WA keessatti

Qorannoo 13 Myeloma Baay’ee f Tacoma fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Puyallup · Miili 8 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07391657

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
  • NorthWest Medical Specialties, PLLC, Tacoma
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07518186

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

Namoota walitti qabaa jiraSadarkaa 4
  • Northwest Medical Specialties, PLLC, Tacoma
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07609940

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
  • NorthWest Medical Specialties, PLLC, Tacoma
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05552222

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • American Oncology Network Vista Oncology Division / Physician partner associate, Olympia · Miili 26 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07477587

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Northwest Medical Specialties, Tacoma
  • Northwest Medical Specialties, Gig Harbor · Miili 8 fagaatti
  • Northwest Medical Specialties, Puyallup · Miili 8 fagaatti
  • fi 1 dabalataa
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT02693535

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06953960

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • Northwest Medical Specialties, Tacoma
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT05651932

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Puyallup · Miili 8 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT07764978

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT05650632

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Namoota walitti qabaa jiraSadarkaa 3
  • Providence Regional Cancer System-Yelm, Yelm · Miili 23 fagaatti
  • Providence Regional Cancer System-Lacey, Lacey · Miili 23 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT05561387

Qorannoo Myeloma Baay’ee magaalota biroo keessatti

Qorannoo biroo Tacoma keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.